Professor Michael Sefton of the University of Toronto was the first to recognize the importance of combining living cells with synthetic polymers to create ‘artificial’ organs and tissues, a field now known as tissue engineering. His work can be summarized in three words: original, significant and scholarly. His current ground breaking research into the creation of modular tissue components seeks to create cardiac muscle to treat heart failure and pancreatic tissue for diabetes, among other possibilities.

Supported by

Platinum

TD Insurance Logo (English)
Manulife Logo (English)

Silver

Canada Life Logo (English)
Victor Logo